Axsome Therapeutics target price cut to $245 from $267 by Deutsche Bank
AXSM•Deutsche Bank cut its target price for Axsome Therapeutics to $245 from $267.
Related News
Australian Oilseeds delays annual report to finalize financial statements
COOT•
Home Depot sets third-quarter earnings conference call
HD•
RTX's Raytheon wins DARPA contract to develop light-based signal processing technology
RTX•
XMax board authorizes up to $30 million share repurchase program
XMAX•
Even stingy Apple endures AI collateral damage
AAPL•